AUTHORS HAVE INDICATED THAT THE SEQUENCING RESULT OF THE PLASMID USED SHOWED A ILE IN POSITION 4. ...AUTHORS HAVE INDICATED THAT THE SEQUENCING RESULT OF THE PLASMID USED SHOWED A ILE IN POSITION 4. THIS SEQUENCE CONFLICT IS ALSO ALREADY REPORTED IN THE UNIPROT ENTRY P15121
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 2.17 Å3/Da / 溶媒含有率: 43.37 %
結晶化
温度: 291 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 5 詳細: Crystallization solution: 50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+= 0.66 g/L and Human Aldose Reductase= 15 mg/ml. 9 microliter of the crystallization ...詳細: Crystallization solution: 50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+= 0.66 g/L and Human Aldose Reductase= 15 mg/ml. 9 microliter of the crystallization solution were mixed with 3 microliter of a 5 mM solution of the inhibitor in 120 mM di-Ammoniumhydrogen citrate pH 5.0 with 25 % (m/V) PEG 6000 and 5 % DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 291K